Brett Kavaja

Director, Commercial Development, Global Commercial Strategy at PTC Therapeutics

Brett Kavaja has extensive experience in the pharmaceutical industry, with a focus on commercial development and marketing. Brett currently holds the position of Director of Commercial Development at PTC Therapeutics. Prior to this, they worked at Bristol Myers Squibb as the Director of Global Marketing, leading commercialization efforts for early assets and providing strategic guidance for product teams. Brett also had roles at Eisai US as the Director of Global Oncology Commercial Development and Associate Director of Oncology Global Marketing, at Daiichi Sankyo as a Senior Manager of Portfolio & New Business Planning, at Abraxis Bioscience as a Manager of US/Global Marketing Intelligence & Forecasting, at NovoNordisk as a Manager of US Brand Marketing, and at Bayer as a Global Marketing Analyst and Supervising Analytical Chemist.

Brett Kavanaugh has obtained a Bachelor's degree in Chemistry from West Virginia University. Brett has also earned a Master of Business Administration degree with a specialization in Marketing from Fairleigh Dickinson University.

Location

New York, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


PTC Therapeutics

11 followers

PTC is a science-driven, patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare disease.